AACR Cancer Progress Report 2016
暂无分享,去创建一个
William Pao | Thomas J. Smith | Thomas J Smith | Monica Morrow | Scott A Armstrong | Ralph J DeBerardinis | James H Doroshow | S. Armstrong | R. Deberardinis | W. Pao | E. Platz | L. Coussens | J. Doroshow | M. Morrow | P. Hwu | C. Willman | N. Davidson | T. Kensler | M. Cruz-Correa | Patrick Hwu | Thomas W Kensler | Lisa M Coussens | Nancy E Davidson | Elizabeth A Platz | Cheryl L Willman | Margaret Foti | Marcia R Cruz-Correa | Charles G Mulligan | M. Foti | Charles G. Mulligan
[1] R. Lew,et al. Prevention and early detection strategies for melanoma and skin cancer. Current status. , 1996, Archives of dermatology.
[2] A. Jemal,et al. Where Can Colorectal Cancer Screening Interventions Have the Most Impact? , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[3] J. Blay,et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial , 2016, The Lancet.
[4] W. Willett,et al. Early Life Body Fatness and Risk of Colorectal Cancer in U.S. Women and Men—Results from Two Large Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[5] R. Gelber,et al. Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Ravaud,et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.
[7] Gretchen A. Stevens,et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.
[8] S. Nelson,et al. Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy , 2010, Clinical Cancer Research.
[9] L. Crinò,et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.
[10] Oliver N Keene,et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.
[11] Chien-Jen Chen,et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.
[12] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[13] M. Vidyasagar,et al. Effectiveness of pranayama on cancer-related fatigue in breast cancer patients undergoing radiation therapy: A randomized controlled trial , 2015, International journal of yoga.
[14] C. Klabunde,et al. Vital Signs: Colorectal Cancer Screening Test Use — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.
[15] Gail M Williams,et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] W. Willett,et al. Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study , 2016, British Medical Journal.
[17] T. Rebbeck. Precision Prevention of Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[18] Office on Smoking. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .
[19] Nicholas J Shaheen,et al. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.
[20] Julia H. Rowland,et al. Mental and Physical Health–Related Quality of Life among U.S. Cancer Survivors: Population Estimates from the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[21] Jeffrey W. Clark,et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.
[22] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[23] Thomas C Wright,et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. , 2011, The Lancet. Oncology.
[24] Janet E. Fulton,et al. Vital signs: walking among adults--United States, 2005 and 2010. , 2012, MMWR. Morbidity and mortality weekly report.
[25] S. Nass,et al. Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology: Workshop Summary , 2016 .
[26] D. Rein,et al. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[27] E. Giovannucci,et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk , 2015, Gut.
[28] J. Singer,et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. , 2013, JAMA.
[29] K. Syrigos,et al. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial. , 2015, The Lancet. Oncology.
[30] C. Rudin,et al. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.
[31] Stuart L Schreiber,et al. AACR Cancer Progress Report 2012 , 2012, Clinical Cancer Research.
[32] S. Holmberg,et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988‐2012 , 2016, Hepatology.
[33] Anthony Fyles,et al. Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.
[34] J. Maris,et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. , 2013, The Lancet. Oncology.
[35] Use of indoor tanning devices by adults--United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.
[36] James C Yao,et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study , 2016, The Lancet.
[37] S. Michie,et al. Gradual Versus Abrupt Smoking Cessation , 2016, Annals of Internal Medicine.
[38] E. Mardis,et al. AACR Cancer Progress Report 2014 , 2014, Clinical Cancer Research.
[39] Education Welfare.,et al. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .
[40] M. Chren,et al. International prevalence of indoor tanning: a systematic review and meta-analysis. , 2014, JAMA dermatology.
[41] J. Engelman,et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. , 2014, The New England journal of medicine.
[42] A. Giuliano,et al. Ten-year survival results of ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node (Alliance). , 2016 .
[43] Stephanie R. Morain,et al. Have Tobacco 21 Laws Come of Age? , 2016, The New England journal of medicine.
[44] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[45] M. Millenson,et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. , 2015, The New England journal of medicine.
[46] M. Pishvaian,et al. Current management of inflammatory bowel disease and colorectal cancer. , 2011, Gastrointestinal cancer research : GCR.
[47] Y. Shentu,et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial , 2016, The Lancet.
[48] M. Irwin,et al. Yoga for persistent fatigue in breast cancer survivors , 2012, Cancer.
[49] Sameer M. Siddiqi,et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.
[50] Laura Kann,et al. Youth risk behavior surveillance--United States, 2013. , 2014, MMWR supplements.
[51] Marc Peeters,et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. , 2015, The New England journal of medicine.
[52] M. Makary,et al. Underreporting of Robotic Surgery Complications , 2015, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.
[53] D. Teachey,et al. T Cells Engineered With a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Produce Significant In Vivo Proliferation, Complete Responses and Long-Term Persistence Without Gvhd In Children and Adults With Relapsed, Refractory ALL , 2013 .
[54] Pranesh P. Chowdhury,et al. Surveillance for Certain Health Behaviors, Chronic Diseases, and Conditions, Access to Health Care, and Use of Preventive Health Services Among States and Selected Local Areas - Behavioral Risk Factor Surveillance System, United States, 2012. , 2016, Morbidity and mortality weekly report. Surveillance summaries.
[55] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[56] R. Bourgon,et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial , 2016, The Lancet.
[57] Elaine R Mardis,et al. AACR Cancer Progress Report 2013 , 2013, Clinical Cancer Research.
[58] Rachel L. Thompson,et al. Policy and action for cancer prevention , 2010, Perspectives in public health.
[59] T. Skolarus,et al. American Cancer Society prostate cancer survivorship care guidelines , 2014, CA: a cancer journal for clinicians.
[60] A. Ziogas,et al. Sociodemographic Disparities in Advanced Ovarian Cancer Survival and Adherence to Treatment Guidelines , 2015, Obstetrics and gynecology.
[61] R. Pazdur,et al. Seamless Oncology-Drug Development. , 2016, The New England journal of medicine.
[62] G. Armstrong,et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. , 2013, JAMA.
[63] L. Ku,et al. Health Care Reform and Women’s Insurance Coverage for Breast and Cervical Cancer Screening , 2012, Preventing chronic disease.
[64] J. Lunceford,et al. Pembrolizumab for the treatment of non-small-cell lung cancer. , 2015, The New England journal of medicine.
[65] T. Holford,et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. , 2014, JAMA.
[66] A. Hauschild,et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial , 2012, The Lancet.
[67] C. Karema,et al. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. , 2012, Bulletin of the World Health Organization.
[68] Robin L. Jones,et al. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] P. Scheet,et al. Genomic Landscape of Colorectal Mucosa and Adenomas , 2016, Cancer Prevention Research.
[70] R. Stupp,et al. The Role of Radio- and Chemotherapy in Glioblastoma , 2005, Oncology Research and Treatment.
[71] S. J. Henley,et al. Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.
[72] M. Dolled-Filhart,et al. Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) , 2014 .
[73] P. Jänne,et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. , 2015, The New England journal of medicine.
[74] R. Monina Klevens,et al. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 , 2012, Annals of Internal Medicine.
[75] A. Palumbo,et al. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma. , 2015, The New England journal of medicine.
[76] G. Daniels,et al. Improved median overall survival (OS) in patients with metastatic melanoma (mM) treated with high-dose (HD) IL-2: Analysis of the PROCLAIM 2007-2012 national registry. , 2014 .
[77] Graham A. Colditz,et al. Applying What We Know to Accelerate Cancer Prevention , 2012, Science Translational Medicine.
[78] K. Artyushkova,et al. Elevated Concentrations of U and Co-occurring Metals in Abandoned Mine Wastes in a Northeastern Arizona Native American Community. , 2015, Environmental science & technology.
[79] Brigid M Lynch,et al. Sedentary Behavior and Cancer: A Systematic Review of the Literature and Proposed Biological Mechanisms , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[80] K. Savage,et al. Anaplastic large cell lymphoma, ALK-positive. , 2012, Critical reviews in oncology/hematology.
[81] Heidi Ledford. Old cancer drug gets fresh look , 2014, Nature.
[82] L. Presta,et al. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.
[83] K. Schmitz,et al. Weight Lifting and Physical Function Among Survivors of Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] W. Mechelen,et al. The economic burden of physical inactivity: a global analysis of major non-communicable diseases , 2016, The Lancet.
[85] M. Dolled-Filhart,et al. A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer. , 2014 .
[86] P. Moore,et al. Merkel cell carcinoma: a virus-induced human cancer. , 2012, Annual review of pathology.
[87] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[88] J. Roberts. News of Science , 1956, Science.
[89] B. Lushniak,et al. The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .
[90] J. Wolchok,et al. Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL). , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] R. DeRubeis,et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] Kassandra I. Alcaraz,et al. Prevalence and Correlates of Smoking and Cessation-Related Behavior among Survivors of Ten Cancers: Findings from a Nationwide Survey Nine Years after Diagnosis , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[93] David C. Smith,et al. Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis. , 2014 .
[94] Gail M. Williams,et al. Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use , 2006, Cancer Epidemiology Biomarkers & Prevention.
[95] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[96] Sanjay G. Patel,et al. Comparison of Perioperative and Early Oncologic Outcomes between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort. , 2016, The Journal of urology.
[97] G. Guy,et al. Sunburn and sun protective behaviors among adults aged 18-29 years--United States, 2000-2010. , 2012, MMWR. Morbidity and mortality weekly report.
[98] J. Taube,et al. Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial. , 2014 .
[99] W. Maziak,et al. Waterpipe tobacco smoking: an emerging health crisis in the United States. , 2010, American journal of health behavior.
[100] C. Schumann,et al. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. , 2015, The Lancet. Oncology.
[101] Peter Boyle,et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[102] M. Plummer,et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.
[103] Kurt Straif,et al. A review of human carcinogens--part D: radiation. , 2009, The Lancet. Oncology.
[104] K. Flegal,et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.
[105] A. Iafrate,et al. Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers , 2012, Science Translational Medicine.
[106] Robert A Gardiner,et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study , 2016, The Lancet.
[107] G. Guy,et al. Surgeon General’s Call to Action to Prevent Skin Cancer , 2014, Morbidity and Mortality Weekly Report.
[108] Rebecca L Morgan,et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[109] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[110] E. Emanuel,et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. , 2014, JAMA.
[111] M. Dewhirst,et al. Effects and potential mechanisms of exercise training on cancer progression: A translational perspective , 2013, Brain, Behavior, and Immunity.
[112] S. Gettinger,et al. First-line nivolumab (anti-PD-1; BMS-936558, ONO-4538) monotherapy in advanced NSCLC: Safety, efficacy, and correlation of outcomes with PD-L1 status. , 2014 .
[113] Greta M. Massetti,et al. Vital Signs: Melanoma Incidence and Mortality Trends and Projections — United States, 1982–2030 , 2015, MMWR. Morbidity and mortality weekly report.
[114] David Goldstein,et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.
[115] Edward Giovannucci,et al. Diabetes and Cancer , 2010, Diabetes Care.
[116] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[117] J. Hadler,et al. Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions , 2013, Cancer.
[118] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[119] Avrum Spira,et al. Transforming Cancer Prevention through Precision Medicine and Immune-oncology , 2016, Cancer Prevention Research.
[120] Ahmedin Jemal,et al. Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer , 2016, Cancer.
[121] S. Spechler,et al. Barrett esophagus and risk of esophageal cancer: a clinical review. , 2013, JAMA.
[122] Gregory Riely,et al. EGFR: The Paradigm of an Oncogene-Driven Lung Cancer , 2015, Clinical Cancer Research.
[123] Heather L. Mulder,et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. , 2014, The New England journal of medicine.
[124] G. Linette,et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. , 2015, The New England journal of medicine.
[125] Jessica Katz,et al. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma. , 2015, The New England journal of medicine.
[126] G. Colditz,et al. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. , 2012, Annual review of public health.
[127] Frances E. Thompson,et al. Adults Meeting Fruit and Vegetable Intake Recommendations — United States, 2013 , 2015, MMWR. Morbidity and mortality weekly report.
[128] K. Straif,et al. A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. , 2009, The Lancet. Oncology.
[129] F. Hecht,et al. Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. , 2012, Journal of alternative and complementary medicine.
[130] R. Herbst,et al. Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement , 2013, Clinical Cancer Research.
[131] D. Silverman,et al. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. , 2016, Journal of the National Cancer Institute.
[132] Joakim Dillner,et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. , 2010, Journal of the National Cancer Institute.
[133] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[134] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.
[135] D. Sargent,et al. Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial , 2007, Annals of surgery.
[136] K. Schmitz,et al. Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema , 2014, Journal of Cancer Survivorship.
[137] R. Pangrazi,et al. Step It Up , 2009 .
[138] Jennifer A. Doudna,et al. Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.
[139] P. Kantoff,et al. Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.
[140] H. Jessen,et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. , 2011, The New England journal of medicine.
[141] J. Utikal,et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.
[142] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[143] Brian A. King,et al. Tobacco Use Among Middle and High School Students--United States, 2011-2015. , 2016, MMWR. Morbidity and mortality weekly report.
[144] K. Straif,et al. A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.
[145] Troy Guthrie,et al. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[146] Kurt Straif,et al. The carcinogenicity of outdoor air pollution. , 2013, The Lancet. Oncology.
[147] S. Stokley,et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014 , 2015, MMWR. Morbidity and mortality weekly report.
[148] M. Fiore,et al. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research , 2016, Clinical Cancer Research.
[149] S. el-Halabi,et al. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013. , 2015, MMWR. Morbidity and mortality weekly report.
[150] F. Marincola,et al. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.
[151] Manal M. Hassan,et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[152] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[153] D. Dwyer,et al. Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010. , 2011, MMWR. Morbidity and mortality weekly report.
[154] J. Gribben,et al. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial. , 2016, The Lancet. Oncology.
[155] T. Robak,et al. New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies , 2011, BioDrugs.
[156] R. Hicks,et al. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.
[157] J. Lunceford,et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. , 2016, The Lancet. Oncology.
[158] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[159] N. Mandel,et al. Messages from the Food Police: How Food-Related Warnings Backfire among Dieters , 2015, Journal of the Association for Consumer Research.
[160] E. Giovannucci,et al. Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. , 2016, JAMA oncology.
[161] Richard E. Harris,et al. Investigation of 2 Types of Self-administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors: A Randomized Clinical Trial. , 2016, JAMA oncology.
[162] Jillian E. Schreiber,et al. Update on Post‐mastectomy Lymphedema Management , 2016, The breast journal.
[163] Noele P. Nelson,et al. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. , 2016, Morbidity and mortality weekly report. Surveillance summaries.
[164] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[165] Mark T Hegel,et al. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[166] Joanne S Haviland,et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. , 2013, The Lancet. Oncology.
[167] J. Manyika. Big data: The next frontier for innovation, competition, and productivity , 2011 .
[168] B. Stewart,et al. World cancer report 2014. , 2014 .
[169] S. Gabriel,et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma , 2015, Science.
[170] Antoni Ribas,et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.
[171] Y. Im,et al. Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[172] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2005–2012 , 2014, MMWR. Morbidity and mortality weekly report.
[173] Supriya G Mohile,et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[174] P. Ascierto,et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. , 2014, The New England journal of medicine.
[175] A. Fournier,et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. , 2016, JAMA internal medicine.
[176] J. Cuzick,et al. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial , 2014, The Lancet.
[177] J. Wolchok,et al. Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[178] Christian Pilarsky,et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. , 2009, Clinical chemistry.
[179] J. T. Cox,et al. Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening , 2004, Obstetrics and gynecology.
[180] K. Flaherty,et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.
[181] M. Socinski,et al. Phase 2 prospective analysis of alectinib in ALK-positive, crizotinib-resistant non-small-cell lung cancer , 2015, The Lancet. Oncology.
[182] P. Sasieni,et al. 13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010 , 2011, British Journal of Cancer.
[183] A. Alwan. Global status report on noncommunicable diseases 2010. , 2011 .
[184] E. Olsen,et al. State indoor tanning laws and adolescent indoor tanning. , 2014, American journal of public health.
[185] Michael Thomas,et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. , 2013, The New England journal of medicine.
[186] Maria Bjurberg,et al. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients , 2003, Supportive Care in Cancer.
[187] J. Wolchok,et al. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. , 2016, JAMA.
[188] M. Kamdar,et al. Early integrated palliative care to improve family caregivers (FC) outcomes for patients with gastrointestinal and lung cancer. , 2016 .
[189] S. Habib,et al. Diabetes and Risk of Cancer , 2013, ISRN oncology.
[190] J. Larkin,et al. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. , 2015, The Lancet. Oncology.
[191] Jeannine S. Schiller,et al. Summary health statistics for U.S. adults: National Health Interview Survey, 2001. , 2004, Vital and health statistics. Series 10, Data from the National Health Survey.
[192] Yan-Shen Shan,et al. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial , 2016, The Lancet.
[193] D. Lowy,et al. Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial , 2013, Cancer Prevention Research.
[194] C. Nanni,et al. 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT , 2015, Clinical nuclear medicine.
[195] W. Woodward,et al. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. , 2015, JAMA oncology.
[196] Target Validation Team. Dysregulated metabolism contributes to oncogenesis , 2015 .
[197] Mellar P. Davis,et al. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. , 2015, Annals of palliative medicine.
[198] Alona Muzikansky,et al. Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.
[199] Michael Hallek,et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. , 2014, The New England journal of medicine.
[200] R. Jagsi,et al. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. , 2015, JAMA oncology.
[201] Brian A. King,et al. Vital Signs: Exposure to Electronic Cigarette Advertising Among Middle School and High School Students - United States, 2014. , 2016, MMWR. Morbidity and mortality weekly report.
[202] G. Freeman,et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.
[203] Parth D. Shah,et al. Quality of Physician Communication about Human Papillomavirus Vaccine: Findings from a National Survey , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[204] B. Pizacani,et al. Demonstrating the importance and feasibility of including sexual orientation in public health surveys: health disparities in the Pacific Northwest. , 2010, American journal of public health.
[205] S. Franceschi,et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.
[206] Janet E. Fulton,et al. Adult Participation in Aerobic and Muscle-Strengthening Physical Activities — United States, 2011 , 2013, MMWR. Morbidity and mortality weekly report.
[207] J L Collins,et al. Youth Risk Behavior Surveillance--United States, 1997. State and Local YRBSS Coordinators. , 1998, The Journal of school health.
[208] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.
[209] G. Gordon,et al. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. , 2016, The Lancet. Oncology.
[210] M. Greene,et al. Concise handbook of familial cancer susceptibility syndromes - second edition. , 2008, Journal of the National Cancer Institute. Monographs.
[211] G. Daniels,et al. High dose (HD) IL-2 for metastatic renal cell carcinoma (mRCC) in the targeted therapy era: Extension of OS benefits beyond complete response (CR) and partial response (PR). , 2014 .
[212] W. T. Vonstille,et al. Radon and cancer , 1990 .
[213] Kirsten Bibbins-Domingo,et al. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. , 2016, Annals of internal medicine.
[214] M. Fine,et al. Systematic Review and Meta-Analysis of Inhaled Toxicants from Waterpipe and Cigarette Smoking , 2016, Public health reports.
[215] A. Giobbie-Hurder,et al. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. , 2014, The New England journal of medicine.
[216] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[217] M. Hallek,et al. Management of chronic lymphocytic leukemia , 2014, Haematologica.
[218] Connie Lim,et al. Youth Risk Behavior Surveillance - United States, 2015. , 2016, Morbidity and mortality weekly report. Surveillance summaries.
[219] A. Hartman,et al. The association between demographic and behavioral characteristics and sunburn among U.S. adults - National Health Interview Survey, 2010. , 2014, Preventive medicine.
[220] Yi-Fang Chang,et al. Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis. , 2015, Journal of alternative and complementary medicine.
[221] Nikki A. Hawkins,et al. Patterns of sunscreen use on the face and other exposed skin among US adults. , 2015, Journal of the American Academy of Dermatology.
[222] Lindsey A. Torre,et al. Cancer Facts & Figures for Hispanics/Latinos 2012-2014 , 2009 .
[223] M. LeFevre. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: U.S. Preventive Services Task Force Recommendation Statement , 2014 .
[224] K. Straif,et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.
[225] R. Croyle,et al. Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 , 2016, Public health reports.
[226] Wendy Leisenring,et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. , 2010, Journal of the National Cancer Institute.
[227] P. Nathan,et al. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. , 2016, The New England journal of medicine.
[228] Jennifer A. Hobin,et al. Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology , 2015, Clinical Cancer Research.
[229] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[230] A. Palumbo,et al. Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. , 2016, The New England journal of medicine.
[231] C. Wheeler,et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. , 2012, The Lancet. Oncology.
[232] J. Haldane,et al. The Genetics of Cancer , 1933, Nature.
[233] Christopher S. Carpenter,et al. Disparities in health insurance coverage, access, and outcomes for individuals in same-sex versus different-sex relationships, 2000-2007. , 2010, American journal of public health.
[234] E. Feuer,et al. Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000 , 2012, Journal of the National Cancer Institute.
[235] G. Ioannou. Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey , 2011, Annals of Internal Medicine.
[236] C. Fuchs,et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.
[237] Nina Bhardwaj,et al. AACR Cancer Progress Report 2015 , 2015, Clinical Cancer Research.
[238] B. Graubard,et al. Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.